Clinical Trial Report

Bioequivalence and Pharmacokinetic Evaluation of Two Oral Formulations of Regorafenib: An Open-Label, Randomised, Single-Dose, Two-Period, Two-Way Crossover Clinical Trial in Healthy Chinese Volunteers Under Fasting and Fed Conditions

Zhang Q, Wang Z, Wu J, Zhou Z, Zhou R, Hu W

Drug Design, Development and Therapy 2021, 15:3277-3288

Published Date: 29 July 2021